CD274 and neoplasm: Taken together, these results suggest that CISP could enhance the tumor targeting of nanoparticles by binding to PD-L1 on tumor cells, and PD-L1 is delivered to lysosomes along with CISP, thereby reducing PD-L1 on tumor cells membrane induced by SR-717, which enhanced the activity of T cells to kill B16F10 cells33.